| |
| |
| Exchange: |
American Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
5,530,000 |
| Market
Cap: |
14.30(M) |
| Last
Volume: |
18,478 |
Avg
Vol: |
19,139 |
| 52
Week Range: |
$2.06 - $5.55 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Laboratories & Research |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Psychemedics provides testing services for the detection of drugs of abuse through the analysis of hair samples. Co.'s testing methods utilize a technology that digests the hair and releases drugs trapped in the hair without destroying the drugs. Co. provides screening and confirmation by mass spectrometry for cocaine, marijuana, PCP, amphetamines (including ecstasy, eve and Adderall®), opiates (including heroin, hydrocodone, hydromorphone, oxycodone, oxymorphone and codeine), synthetic cannabinoids (including K2, Spice, Blaze), benzodiazepines (Xanax®, Valium®, and Ativan®), nicotine and Fentanyl.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
100 |
| Total Buy Value |
$0 |
$0 |
$0 |
$495 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
1 |
| Total Shares Sold |
0 |
0 |
12,700 |
12,700 |
| Total Sell Value |
$0 |
$0 |
$59,182 |
$59,182 |
| Total People Sold |
0 |
0 |
1 |
1 |
| Total Sell Transactions |
0 |
0 |
1 |
1 |
| End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Weisenhoff Michael |
Assistant Controller |
– – – |
2023-08-17 |
4 |
A |
$0.00 |
$0 |
D/D |
4,000 |
4,000 |
|
- |
|
| Davis Robyn C |
Director |
– • – |
2023-08-17 |
4 |
A |
$0.00 |
$0 |
D/D |
14,000 |
39,000 |
|
- |
|
| Kamin Peter H |
Director |
– • • |
2023-08-17 |
4 |
A |
$0.00 |
$0 |
D/D |
14,000 |
237,031 |
|
- |
|
| Reynolds Andrew |
Director |
– • – |
2023-08-17 |
4 |
A |
$0.00 |
$0 |
D/D |
14,000 |
28,000 |
|
- |
|
| Doucot Charles M |
Executive Vice President |
• – – |
2023-08-17 |
4 |
S |
$4.66 |
$59,182 |
D/D |
(12,700) |
23,250 |
|
39% |
|
| Nevin Darius G |
See Footnote 1 |
– • – |
2023-08-17 |
4 |
A |
$0.00 |
$0 |
D/D |
14,000 |
23,000 |
|
- |
|
| Kubacki Raymond C Jr |
Chairman, CEO & President |
• • – |
2023-05-22 |
4 |
D |
$4.93 |
$7,395 |
D/D |
(1,500) |
246,737 |
|
- |
|
| Doucot Charles M |
Executive Vice President |
• – – |
2023-05-22 |
4 |
D |
$4.93 |
$4,067 |
D/D |
(825) |
35,950 |
|
- |
|
| Schaffer Michael I |
VP of Laboratory Operations |
• – – |
2023-05-22 |
4 |
D |
$4.93 |
$1,849 |
D/D |
(375) |
36,489 |
|
- |
|
| Doucot Charles M |
Executive Vice President |
• – – |
2023-05-15 |
4 |
D |
$4.87 |
$4,383 |
D/D |
(900) |
36,775 |
|
- |
|
| Schaffer Michael I |
VP of Laboratory Operations |
• – – |
2023-05-15 |
4 |
D |
$4.87 |
$1,641 |
D/D |
(337) |
36,864 |
|
- |
|
| Kubacki Raymond C Jr |
Chairman, CEO & President |
• • – |
2023-05-15 |
4 |
D |
$4.87 |
$8,401 |
D/D |
(1,725) |
248,237 |
|
- |
|
| Schaffer Michael I |
VP of Laboratory Operations |
• – – |
2022-12-16 |
4 |
B |
$4.95 |
$495 |
D/D |
100 |
37,201 |
2.66 |
10% |
|
| Kubacki Raymond C Jr |
Chairman, CEO & President |
• • – |
2022-11-11 |
4 |
D |
$6.18 |
$16,223 |
D/D |
(2,625) |
249,962 |
|
- |
|
| Schaffer Michael I |
VP of Laboratory Operations |
• – – |
2022-11-11 |
4 |
D |
$6.18 |
$3,245 |
D/D |
(525) |
37,101 |
|
- |
|
| Doucot Charles M |
Executive Vice President |
• – – |
2022-11-11 |
4 |
D |
$6.18 |
$8,343 |
D/D |
(1,350) |
37,675 |
|
- |
|
| Kamin Peter H |
Director |
– • • |
2022-08-12 |
4 |
A |
$0.00 |
$0 |
D/D |
9,000 |
223,031 |
|
- |
|
| Nevin Darius G |
See Footnote 1 |
– • – |
2022-08-12 |
4 |
A |
$0.00 |
$0 |
D/D |
9,000 |
9,000 |
|
- |
|
| Doucot Charles M |
Executive Vice President |
• – – |
2022-05-20 |
4 |
A |
$0.00 |
$0 |
D/D |
11,000 |
39,025 |
|
- |
|
| Reynolds Andrew |
Director |
– • – |
2022-05-20 |
4 |
A |
$0.00 |
$0 |
D/D |
12,000 |
14,000 |
|
- |
|
| Davis Robyn C |
Director |
– • – |
2022-05-20 |
4 |
A |
$0.00 |
$0 |
D/D |
12,000 |
25,000 |
|
- |
|
| Schaffer Michael I |
VP of Laboratory Operations |
• – – |
2022-05-20 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
37,626 |
|
- |
|
| Tomenson Walter S |
Director |
– • – |
2022-05-20 |
4 |
A |
$0.00 |
$0 |
D/D |
12,000 |
74,399 |
|
- |
|
| Weinert Fred J |
Director |
– • – |
2022-05-20 |
4 |
A |
$0.00 |
$0 |
D/D |
12,000 |
71,583 |
|
- |
|
| Limbek Andrew |
Vice President & Controller |
• – – |
2022-05-20 |
4 |
A |
$0.00 |
$0 |
D/D |
7,000 |
13,863 |
|
- |
|
217 Records found
|
|
Page 1 of 9 |
|
|
0.02 (0.58%) 
